STERIS plc (NYSE:STE – Get Free Report) Director Mohsen Sohi sold 4,893 shares of the firm’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $253.22, for a total transaction of $1,239,005.46. Following the completion of the transaction, the director owned 24,305 shares in the company, valued at approximately $6,154,512.10. The trade was a 16.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
STERIS Trading Down 1.1%
NYSE:STE opened at $253.50 on Friday. STERIS plc has a 12-month low of $195.14 and a 12-month high of $269.44. The firm has a market capitalization of $24.62 billion, a P/E ratio of 30.07 and a beta of 0.86. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.05 and a quick ratio of 1.44. The business has a 50 day simple moving average of $222.55 and a 200 day simple moving average of $224.61.
STERIS (NYSE:STE – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 EPS for the quarter, beating the consensus estimate of $2.68 by $0.26. STERIS had a net margin of 13.41% and a return on equity of 14.80%. The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the business earned $2.47 earnings per share. STERIS’s revenue was up 8.8% compared to the same quarter last year. Equities research analysts predict that STERIS plc will post 11.46 EPS for the current year.
STERIS Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Tuesday, November 17th will be issued a $0.69 dividend. This represents a $2.76 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, November 17th. STERIS’s dividend payout ratio is 32.74%.
Analysts Set New Price Targets
Several analysts recently commented on STE shares. Weiss Ratings upgraded STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday. KeyCorp increased their price target on STERIS from $269.00 to $284.00 and gave the stock an “overweight” rating in a research note on Friday, November 6th. Jefferies Financial Group raised STERIS from a “hold” rating to a “buy” rating in a report on Friday. Morgan Stanley raised STERIS from an “overweight” rating to a “buy” rating in a report on Friday. Finally, UBS Group cut their price objective on shares of STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research note on Friday, August 7th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $276.33.
Check Out Our Latest Stock Analysis on STE
Institutional Investors Weigh In On STERIS
Hedge funds and other institutional investors have recently made changes to their positions in the company. Wellington Management Group LLP lifted its stake in STERIS by 21.9% in the second quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider’s stock valued at $737,605,000 after acquiring an additional 629,532 shares during the last quarter. Janus Henderson Group PLC lifted its position in STERIS by 25.7% in the first quarter. Janus Henderson Group PLC now owns 1,863,139 shares of the medical equipment provider’s stock worth $411,995,000 after purchasing an additional 380,504 shares during the period. Dimensional Fund Advisors LP increased its stake in STERIS by 4.3% in the first quarter. Dimensional Fund Advisors LP now owns 1,113,845 shares of the medical equipment provider’s stock valued at $246,295,000 after acquiring an additional 46,391 shares during the period. Bessemer Group Inc. grew its stake in shares of STERIS by 8.8% in the 1st quarter. Bessemer Group Inc. now owns 1,048,636 shares of the medical equipment provider’s stock valued at $231,883,000 after purchasing an additional 85,188 shares during the period. Finally, Principal Financial Group Inc. grew its position in STERIS by 1.0% in the first quarter. Principal Financial Group Inc. now owns 890,562 shares of the medical equipment provider’s stock valued at $196,931,000 after acquiring an additional 9,226 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.
About STERIS
STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.
Featured Articles
- Five stocks we like better than STERIS
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
